Eloxx Pharmaceuticals, Inc.(ELOX)

$15.07—Stale · unknown old

Chart

Eloxx Pharmaceuticals, Inc.(ELOX)

NASDAQ • Last print unknown ago

$15.07—Stale · unknown old

Chart Studio

ELOX(ELOX)

ELOX

Overview Fair Value Stream Notebook Intel Chart History Fundamentals TTM Earnings Analysts News Financials Insiders Institl.DCF Peers

Q4 2026 EPS Estimate

$-0.65

Nov 11, 2026

Analyst Sentiment

Wall St. Consensus

Buy

12 analysts·Moderate coverage

Score

9 Buy (75%)3 Hold (25%)0 Sell (0%)

Rating Breakdown

Strong Buy

00%

Buy

975%

Hold

325%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear

$38.00

+152.2%

Consensus

$40.50

+168.7%

Bull

$43.00

+185.3%

12-Month Target Range12 analysts

$38.00$40.50$43.00

Current $15.07Consensus

Current Price

$15.07

Upside to Consensus

$25.43

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev—

EPS—

FY2028

Rev—

EPS—

FY2029

Rev—

EPS—

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E	FY2029E	FY2030E
Revenue Avg	—	$174M	—	—	—
Low	—	$174M	—	—	—
High	—	$174M	—	—	—
EBITDA Avg	—	$-2M	—	—	—
Low	—	$-3M	—	—	—
High	—	$-832,887	—	—	—
EBIT Avg	—	$-2M	—	—	—
Low	—	$-3M	—	—	—
High	—	$-916,855	—	—	—
Net Income Avg	$-3M	$-3M	$-3M	$-3M	$-3M
Low	$-3M	$-4M	$-3M	$-3M	$-3M
High	$-3M	$-2M	$-3M	$-3M	$-3M
EPS Avg	$-2.65	$-2.69	$-2.52	$-2.44	$-2.90
Low	$-2.65	$-3.57	$-2.52	$-2.44	$-2.90
High	$-2.65	$-1.81	$-2.52	$-2.44	$-2.90
Analysts (Rev / EPS)	— / 1	1 / 2	— / 1	— / 1	— / 1

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027	Q1 2028	Q2 2028
Revenue Avg	—	$2M	$2M	$2M	$2M	$700,000	$700,000	$700,000
Low	—	$2M	$2M	$2M	$2M	$700,000	$700,000	$700,000
High	—	$2M	$2M	$2M	$2M	$700,000	$700,000	$700,000
EBITDA Avg	—	$-5M	$-403M	$-336M	$-358M	$-328M	$-222M	$-190M
Low	—	$-5M	$-403M	$-336M	$-358M	$-328M	$-222M	$-190M
High	—	$-5M	$-403M	$-336M	$-358M	$-328M	$-222M	$-190M
EBIT Avg	—	$-5M	$-403M	$-336M	$-358M	$-328M	$-222M	$-190M
Low	—	$-5M	$-403M	$-336M	$-358M	$-328M	$-222M	$-190M
High	—	$-5M	$-403M	$-336M	$-358M	$-328M	$-222M	$-190M
Net Income Avg	$-4M	$-5M	$-403M	$-336M	$-358M	$-329M	$-222M	$-190M
Low	$-4M	$-5M	$-403M	$-336M	$-358M	$-329M	$-222M	$-190M
High	$-4M	$-5M	$-403M	$-336M	$-358M	$-329M	$-222M	$-190M
EPS Avg	$-0.65	$-0.72	$-59.40	$-49.50	$-52.80	$-48.40	$-32.67	$-28.05
Low	$-0.65	$-0.72	$-59.40	$-49.50	$-52.80	$-48.40	$-32.67	$-28.05
High	$-0.65	$-0.72	$-59.40	$-49.50	$-52.80	$-48.40	$-32.67	$-28.05
Analysts (Rev / EPS)	— / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1

Earnings Surprises

Recent Analyst Actions

Aug 20, 2026Loop Capital Markets

Lucid Capital Markets Starts Eloxx Pharma (ELOX) at Buy

Target:$38.00

+109.3%from $18.16

Jul 20, 2026Guggenheim

Eloxx Pharmaceuticals initiated with a Buy at Guggenheim

Target:$43.00

+258.3%from $12.00

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance